Semaglutide is making waves as a novel treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and reducing glucagon https://lanceatcg748110.fare-blog.com/35902023/understanding-semaglutide-a-comprehensive-guide